Tin tức & Cập nhật
Xem bài viết Nội tiết
Xem
Chỉ hiển thị Multimedia

Amphilimus-eluting stents: As good as zotarolimus-eluting stents in patients with diabetes?
22 Nov 2021
bởiRoshini Claire Anthony
The use of amphilimus-eluting stents (AES) in patients with diabetes mellitus undergoing percutaneous revascularization was less likely to result in target lesion or target vessel failure compared with zotarolimus-eluting stents (ZES) at 1 year, according to findings of the SUGAR trial presented at TCT 2021.
22 Nov 2021



